Wednesday, September 1, 2021

Clinical Data on GenSight Biologics' LUMEVOQ® and GS030 Gene Therapies to be ... - StreetInsider

“The Phase III REFLECT Trial: Efficacy and Safety of Bilateral Gene Therapy for Leber Hereditary Optic Neuropathy (LHON)” will be presented by Bart Leroy, ...
https://www.google.com/url?rct=j&sa=t&url=https://www.streetinsider.com/Business%2BWire/Clinical%2BData%2Bon%2BGenSight%2BBiologics%25E2%2580%2599%2BLUMEVOQ%25C2%25AE%2Band%2BGS030%2BGene%2BTherapies%2Bto%2Bbe%2BPresented%2Bat%2B2021%2BISGEDR%2Band%2BSeveral%2BInvestor%2Band%2BIndustry%2BMeetings%2Bin%2BSeptember/18894110.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEsU1s5GQy2x7RtQUs9yePL6IFgIQ
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...